Skip to content
value.today

Raydiant Oximetry, Inc.

Total raised
$12 M
4 rounds on record
Latest round
$4 M
May 2024
First round on record
May 2019
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Raydiant Oximetry, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2024$4 MNo. 4$2 to $10 million

Raydiant Oximetry, Inc.: Raise no. 4, May 2024

Investors in this round

32 investors had bought by the notice of Jun 11, 2024: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Neil P. Ray · Executive Officer, Director
  • Russ P. DeLonzor · Executive Officer
  • Annie P. Theriault · Director
  • Charles P. McDonald · Director
  • Debra P. Reisenthel · Director
  • Elizabeth P. Bailey · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “This filing covers the sale and purchase of Series A-3 Preferred Stock, and the Common Stock issuable upon conversion thereof.”

Signed by Neil P. Ray, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 11, 2024. Read the notice at the SEC.

equitySEC
Jul 2021$2 MNo. 3$2 to $10 million

Raydiant Oximetry, Inc.: Raise no. 3, Jul 2021

Investors in this round

13 investors had bought by the notice of Jul 29, 2021: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Neil P. Ray · Executive Officer, Director · CHIEF EXECUTIVE OFFICER
  • Russ P. DeLonzor · Executive Officer · PRESIDENT AND CHIEF OPERATING OFFICER
  • Charles F. McDonald · Director
  • Debra F. Reisenthel · Director
  • John F. Maroney · Director
  • Terri F. Burke · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “This filing covers the sale and purchase of Series A-2 Preferred Stock and the Common Stock issuable upon conversion thereof.”

Signed by Neil P. Ray, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 29, 2021. Read the notice at the SEC.

equitySEC
Jun 2019$3 MNo. 2$2 to $10 million

Raydiant Oximetry, Inc.: Raise no. 2, Jun 2019

Investors in this round

25 investors had bought by the notice of Sep 17, 2019: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Neil P. Ray · Executive Officer, Director · Chief Executive Officer
  • Charles P. McDonald · Director
  • Debra P. Reisenthel · Director
  • John P. Maroney · Director
  • Terri P. Burke · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Neil P. Ray, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 17, 2019. Read the notice at the SEC.

equity, optionsSEC
May 2019$2 MNo. 1$2 to $10 million

Raydiant Oximetry, Inc.: Raise no. 1, May 2019

Investors in this round

38 investors had bought by the notice of May 20, 2019: 38 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Neil P. Ray · Executive Officer, Director
  • Charles P. McDonald · Director
  • John P. Maroney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Neil P. Ray, Chief Executive Officer. Source: SEC Form D, newest notice filed May 20, 2019. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Raydiant Oximetry, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2024).

    SEC Form D · Jun 2024

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Jun 2024

That is all the official record says: Raydiant Oximetry, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Raydiant Oximetry, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 38 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Raydiant Oximetry, Inc.
NameRoleNamed in
Neil P. RayExecutive officerJun 2024
Russ P. DeLonzorExecutive officerJun 2024
Annie P. TheriaultDirectorJun 2024
Charles P. McDonaldDirectorJun 2024
Debra P. ReisenthelDirectorJun 2024
Elizabeth P. BaileyDirectorJun 2024
Neil P. RayDirectorJun 2024
Charles F. McDonaldDirectorJul 2021
Debra F. ReisenthelDirectorJul 2021
John F. MaroneyDirectorJul 2021
Terri F. BurkeDirectorJul 2021
John P. MaroneyDirectorSep 2019
Terri P. BurkeDirectorSep 2019